Israel-based medical device developer EarlySense has raised $25 million in a Series G round to bolster the customer base for its continuous monitoring tech to support remote patient monitoring, according to a company statement. It will also use the funding to support its expansion into consumer digital health devices that rely on its FDA-cleared monitoring system.
Read Full Article »
